Author Correction: Impaired CD4
+
T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination
Nat Aging
.
2023 Jun;3(6):751.
doi: 10.1038/s43587-023-00426-w.
Authors
Norihide Jo
1
2
,
Yu Hidaka
3
,
Osamu Kikuchi
4
5
,
Masaru Fukahori
6
7
,
Takeshi Sawada
6
7
,
Masahiko Aoki
6
7
,
Masaki Yamamoto
8
,
Miki Nagao
8
,
Satoshi Morita
3
,
Takako E Nakajima
6
7
,
Manabu Muto
4
5
7
,
Yoko Hamazaki
9
10
Affiliations
1
Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
2
Alliance Laboratory for Advanced Medical Research, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
3
Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
4
Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
5
Clinical Bio-Resource Center, Kyoto University Hospital, Kyoto, Japan.
6
Department of Early Clinical Development, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
7
Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, Kyoto, Japan.
8
Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
9
Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
[email protected]
.
10
Laboratory of Immunobiology, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
[email protected]
.
PMID:
37130979
PMCID:
PMC10153054
DOI:
10.1038/s43587-023-00426-w
No abstract available
Publication types
Published Erratum
Grants and funding
19K23862/MEXT | Japan Society for the Promotion of Science (JSPS)
JP21gm5010005/Japan Agency for Medical Research and Development (AMED)
JP20fk0108454/Japan Agency for Medical Research and Development (AMED)
JP223fa627009/Japan Agency for Medical Research and Development (AMED)